Thirty-six cases originally diagnosed histologically as malignant lymphoma (ML) or anaplastic carcinoma were reexamined immunohistochemically by leukocyte common antigen (LCA) and epithelial membrane antigen (EMA). 5/18 cases originally diagnosed as “anaplastic carcinoma” and “anaplastic carcinoma? (ML to be excluded)” , showed positive staining for LCA and negative for EMA; whereas 3 cases originally diagnosed as malignancy unclassified turned out to be ML, with the relevant assay performed.
This is a preview of subscription content, log in to check access.
Buy single article
Instant access to the full article PDF.
Price includes VAT for USA
Holting T, et al. Immunohistochemical reclassification of anaplastic carcinoma reveals small and giant cell lymphoma. World J Surg 1990; 14:291.
Dean PJ, et al. Application of anti-leukocyte common antigen and anti-cytokeratin antibodies to the biopsy diagnosis of gastric large cell lymphoma. Hum Pathol 1987; 18:918.
Shvero J, et al. Anaplastic thyroid carcinoma. Cancer 1988; 62:319.
Dai YR, et al. Immunohistochemical study on differential diagnosis between nasopharyngeal carcinoma and malignant lymphoma. Chin Med J (Engl) 1989; 102:951.
Mascarel A, et al. Gastric large cell lymphoma expressing cytokeratin but no leucocyte common antigen. Am J Clin Pathol 1989; 91:478.
About this article
Cite this article
Hu, X., Shen, M., Gao, H. et al. The application of immunohistochemistry in the differential diagnosis of extranodal lymphoma and anaplastic carcinoma. Chin J Cancer Res 5, 53–55 (1993). https://doi.org/10.1007/BF02997494
- Immunoenzyme techniques
- Malignant lymphoma
- Anaplastic carcinoma